L&C BIO's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
L&C BIO last closed at ₩56,300 (-3.43%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is -9.6×. Its overall grade ranks 131 of 308 stocks in Healthcare.
About this company
L&C BIO last closed at ₩56,300 (-3.43%) on 2026-10-08. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall B · 131/308
Valuation grade C+
Dividends
2025 dividend per share · ₩50 · Yield 0.08%
Details →Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 메디톡스Competitor
보툴리눔 톡신·미용/재생의학 영역에서 경쟁
- 휴젤Competitor
미용의료·필러/톡신 시장에서 경쟁
- 대웅제약Competitor
보툴리눔 톡신 및 에스테틱 관련 경쟁
ETFs holding this stock
SOL 의료기기소부장Fn · TIGER 의료기기 · HANARO 바이오코리아액티브
Details →About L&C BIO
- What technical signals does L&C BIO (290650) have?
- L&C BIO current technical signals: no active technical signal.
- Is L&C BIO a cup-and-handle pattern?
- No. L&C BIO has no valid Cup signal right now.
- What published figures are available for L&C BIO?
- Market cap: KRW 1.4T. Trailing 12 months PER: -9.6×. Latest quarter PBR: 4.42×. Dividend yield: 0.08%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Disclosed suppliers
2026-03-24 dataset
Turn what you saw on this name into a strategy
Ask Q about L&C BIO, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.